Business Wire06.19.17
Boston Biomedical Associates (BBA) has announced that Dr. Stefan Schreck has joined the management team as executive director, Science and Technology, where he will provide domestic and international clients with pre-clinical strategic technology development assistance.
“Dr. Schreck has an innate ability to help organizations speed up the process for regulatory engagement by facilitating effective discussions between the development teams, the product end users and regulators” noted BBA President and CEO Lauren Baker. “We are very fortunate to have someone of Stefan’s caliber join the BBA team and I know he will be an invaluable asset to our clients as they develop innovative medical treatment solutions.”
From 1986 to 1993, Schreck conducted biomedical research at the University of Houston (Texas); the Georgia Institute of Technology in Atlanta; and the University of Southern California in Los Angeles. Over the next 23 years, he held senior research and development positions at Pfizer and Edwards Lifesciences, and served as the chief technology officer of Endologix and JenaValve. He also advised several med-tech startup companies and successfully secured federal grant funding.
“The global audience that BBA serves is a perfect opportunity for me to apply my 25 years of experience in developing and commercializing innovative medical products,” Schreck said. “I look forward to helping companies pro-actively manage the risks and opportunities of their unique technologies and focus on the key drivers toward a successful clinical outcome.”
Schreck earned his Ph.D. in mechanical engineering from the University of Houston and his M.A. in aerospace engineering from the Technische Hochschule Munchen in Munich, Germany.
In addition to being the inventor on more than 30 U.S. patents, Schreck has published 13 scientific articles on a variety of topics associated with cardiac care and fatigue testing along with publications associated with the structure of the human nose.
Boston Biomedical Associates serves as a strategic partner with clients involved in a variety of medical technologies and working with them throughout the entire medical product life cycle to facilitate bringing new products to market. BBA is also a clinical research organization known for its comprehensive approach to facilitating the clinical trial operations process. The company is based in Marlborough, Mass.
“Dr. Schreck has an innate ability to help organizations speed up the process for regulatory engagement by facilitating effective discussions between the development teams, the product end users and regulators” noted BBA President and CEO Lauren Baker. “We are very fortunate to have someone of Stefan’s caliber join the BBA team and I know he will be an invaluable asset to our clients as they develop innovative medical treatment solutions.”
From 1986 to 1993, Schreck conducted biomedical research at the University of Houston (Texas); the Georgia Institute of Technology in Atlanta; and the University of Southern California in Los Angeles. Over the next 23 years, he held senior research and development positions at Pfizer and Edwards Lifesciences, and served as the chief technology officer of Endologix and JenaValve. He also advised several med-tech startup companies and successfully secured federal grant funding.
“The global audience that BBA serves is a perfect opportunity for me to apply my 25 years of experience in developing and commercializing innovative medical products,” Schreck said. “I look forward to helping companies pro-actively manage the risks and opportunities of their unique technologies and focus on the key drivers toward a successful clinical outcome.”
Schreck earned his Ph.D. in mechanical engineering from the University of Houston and his M.A. in aerospace engineering from the Technische Hochschule Munchen in Munich, Germany.
In addition to being the inventor on more than 30 U.S. patents, Schreck has published 13 scientific articles on a variety of topics associated with cardiac care and fatigue testing along with publications associated with the structure of the human nose.
Boston Biomedical Associates serves as a strategic partner with clients involved in a variety of medical technologies and working with them throughout the entire medical product life cycle to facilitate bringing new products to market. BBA is also a clinical research organization known for its comprehensive approach to facilitating the clinical trial operations process. The company is based in Marlborough, Mass.